Navigation Links
New Imaging Analysis Predicts Brain Tumor Survival
Date:4/20/2009

U-M researchers develop 'parametric response map' to analyze changes in a tumor's blood flow, volume

ANN ARBOR, Mich., April 20 /PRNewswire-USNewswire/ -- As early as one week after beginning treatment for brain tumors, a new imaging analysis method was able to predict which patients would live longer, researchers from the University of Michigan Comprehensive Cancer Center have found.

The method uses a standard magnetic resonance imaging, or MRI, protocol to monitor changes over time in tumor blood volume within individual voxels of the image, rather than a composite view of average change within the tumor. This parametric response map allowed researchers to see specific areas in which tumor blood volume increased or decreased, that may have canceled each other out when looking at the changes as an average.

Results of the study appear in the advance online edition of Nature Medicine.

"What we have potentially is a generalized analytical approach that we can use to quantify treatment intervention in patients," says study author Brian Ross, Ph.D., professor of radiology and biological chemistry at the U-M Medical School and co-director of the Molecular Imaging Program at the U-M Comprehensive Cancer Center.

The researchers looked at 44 people with high-grade glioma, a type of brain tumor, who were treated with chemotherapy and radiation. Each participant underwent MRIs before treatment, and one week and three weeks after starting treatment. The researchers then looked at the relative cerebral blood volume and the relative cerebral blood flow of the tumor to analyze voxel-wise changes among the serial scans.

Looking at standard comparisons using averages, the scans indicated no change one week and three weeks into treatment. But, using the parametric response map approach, the researchers were able to show changes in the tumor's blood volume and blood flow after one week that corresponded to the patient's overall survival.

"We're seeing treatment response earlier into the treatment, and responses that couldn't be detected at all looking at average changes. We could detect this after just one week, which is amazing for brain tumors," says study author Craig Galban, Ph.D., assistant professor of radiology at the U-M Medical School.

High grade gliomas have a high mortality rate, with people surviving only an average of 12 months after diagnosis. Typically, patients receive six to seven weeks of treatment, followed by a traditional MRI scan six weeks after completing therapy to determine if the tumor shrank. If the cancer did not respond to the treatment, a new approach may be tried.

The researchers believe this approach might also be useful with other imaging techniques such as PET and CT scans.

Brain cancer statistics: 21,810 Americans will be diagnosed with brain cancer this year and 13,070 will die from the disease, according to the American Cancer Society

Additional authors: Thomas Chenevert, Ph.D.; Charles Meyer, Ph.D.; Christina Tsien, M.D.; Theodore Lawrence, M.D., Ph.D.; Daniel Hamstra, M.D., Ph.D.; Larry Junck, M.D.; Pia Sundgren, M.D., Ph.D.; Timothy D. Johnson, Ph.D.; David Ross; and Alnawaz Rehemtulla, Ph.D.

Funding: National Institutes of Health

Disclosure: The University of Michigan has filed a patent application on this technology.

Reference: Nature Medicine, doi: 10.1038/nm.1919

Resources:

U-M Cancer AnswerLine, 800-865-1125

U-M Comprehensive Cancer Center, www.mcancer.org


'/>"/>
SOURCE University of Michigan Comprehensive Cancer Center
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
2. Imaging Diagnostic Systems CTLM Technology Presented at Congress of World Society for Breast Health
3. Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System
4. Stereo Mammography Takes Breast Imaging to a New Dimension
5. FluoroPharma Announces Positive Phase I Safety Results for CardioPET(TM), Coronary Artery Disease (CAD) Imaging Tracer for Positron Emission Tomography (PET)
6. Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics
7. FluoroPharma Announces Commencement of Phase I Clinical Trial for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
8. Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging
9. Repligen Receives FDA Fast Track Designation for RG1068 for Pancreatic Imaging
10. Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
11. Imaging Results From the ADAGIO-LIPIDS Reveal That Effects of Rimonabant on Cardiometabolic Risk Profile Include Loss of Visceral Fat and Mobilization of Liver Fat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... CAMBRIDGE, Mass. , Feb. 27, 2017  Infinity ... presenting at the Cowen and Company 37 th ... 4:00 p.m. ET in Boston, MA. ... accessible on the Investors/Media section of Infinity,s website at ... days following the event. About Infinity,Infinity is ...
(Date:2/27/2017)... February 27, 2017 Now in its ... companies that are most successful at developing and commercialising innovation. ... The ... the same molecule to two different companies in early phase, ... on systematic, objective analysis of each company,s performance between 2011 and 2016, ...
(Date:2/27/2017)... Feb. 27, 2017  CTI BioPharma Corp. (CTI BioPharma) (NASDAQ ... Craig , M.D., Ph.D., as President and Chief Executive Officer ... 20, 2017. Dr. Craig succeeds Richard Love , interim ... company,s Board of Directors.  Dr. Craig has over 20 years ... the US and Europe . ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... February 27, 2017 , ... Sunshine Coast Health Centre ... Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the addition of ... showcases the Centre's commitment to innovation in drug rehab and alcohol treatment strategies ...
(Date:2/26/2017)... ... February 25, 2017 , ... The February 13, 2017, assassination of ... concern over nerve agents and the deadly use of chemical weapons. Many questions exist ... how even small doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan ...
(Date:2/26/2017)... ... February 26, 2017 , ... LatitudeC Baby Products, an innovative ... it would be offering some it’s exclusive product line to the public through ... unique baby clothing/feeding products, will team up with AMAZON to distribute a limited ...
(Date:2/26/2017)... ... February 26, 2017 , ... Functional imaging ... according to a study released today at the 1st Pan American Parkinson’s and ... proven to be effective in improving cognitive function in PD patients. This study, ...
(Date:2/24/2017)... ... February 24, 2017 , ... Houston ... at his office, Antoine Dental Center. Currently, patients can get single dental implants ... apply, but patients can learn more about these offers by contacting Antoine Dental ...
Breaking Medicine News(10 mins):